Home > Boards > US Listed > Biotechs > Enochian Biosciences Inc. (ENOB)

On June 8, 2020, Enochian Biosciences, Inc. issued

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
[SMART MONEY]  Member Profile
Member Level 
Followed By 3,774
Posts 141,576
Boards Moderated 13
Alias Born 08/05/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 8:16:28 AM
Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference GlobeNewswire Inc. - 9/13/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/30/2021 1:35:52 PM
Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences’ Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants GlobeNewswire Inc. - 8/30/2021 7:00:00 AM
Distinguished Scientific and Clinical Leader to Join Enochian BioSciences’ Hepatitis B Cure Scientific Advisory Board GlobeNewswire Inc. - 8/23/2021 10:18:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2021 4:29:37 PM
Enochian BioSciences picks Hon. Dr. Mark Dybul as CEO Seeking Alpha - 7/20/2021 7:54:21 AM
Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer GlobeNewswire Inc. - 7/20/2021 7:00:00 AM
Enochian Biosciences shares rise after FDA accepts hepatitis treatment Pre-IND request Seeking Alpha - 7/12/2021 7:44:09 AM
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection GlobeNewswire Inc. - 7/12/2021 7:00:00 AM
Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity GlobeNewswire Inc. - 6/30/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2021 11:50:27 AM
Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treat... GlobeNewswire Inc. - 6/21/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/16/2021 4:10:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/16/2021 8:50:34 AM
Pioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV PR Newswire (US) - 6/15/2021 9:05:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/14/2021 5:16:29 PM
Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire Inc. - 6/14/2021 2:53:19 PM
Enochian Biosciences shares skyrocket after FDA accepts Pre-IND request for HIV treatment Seeking Alpha - 6/14/2021 8:09:38 AM
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure GlobeNewswire Inc. - 6/14/2021 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2021 4:46:46 PM
Enochian Bio reports preliminary data from HIV cell therapy in humans Seeking Alpha - 5/12/2021 9:57:30 AM
A Promising Approach To HIV Cell Therapy, With Exciting Preliminary Results, Was Presented Recently At The Leading Conference... PR Newswire (US) - 5/12/2021 8:05:00 AM
Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 2... GlobeNewswire Inc. - 5/12/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/22/2021 5:02:41 PM
[SMART MONEY] Member Level  Monday, 06/08/20 07:43:53 AM
Re: IPickWinners1 post# 3
Post # of 22 
On June 8, 2020, Enochian Biosciences, Inc. issued a press release announcing the completion of an Initial Targeted Engagement for Regulatory Advice on CBER Products (INTERACT) meeting focused on Enochian’s ENOB-HV-01. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.



The information included in this Item 8.01 and in Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ENOB

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences